STATE-OF-THE-ART BANKING OF UMBILICAL CORD BLOOD TRANSPLANTS AND CURRENT RESULTS ON ALLOGENEIC CB TRANSPLANTATION.
DENDRITIC CELL VACCINATION AND IMMUNE MONITORING
STEM CELL DIFFERENTIATION AND THE ROLE OF EPCS
QUALITY APPROACHES IN CELL THERAPY: PATIENT AND THERAPY-RELATED ASPECTS
GENERATION AND CHARACTERIZATION OF MESENCHYMAL STROMAL CELLS FOR CLINICAL APPLICATION
BLOOD DONATION, MORE THEN A PROCESS
INVENTORY MANAGEMENT AND DISTRIBUTION
PRE-TRANSFUSION TESTING
ANTIBODY RESOLUTION
QUALITY MANAGEMENT IN BLOOD ESTABLISHMENTS
LOOK BACK AND RECALLS
RISK MANAGEMENT IN BLOOD TRANSFUSION
TRANSFUSION OF CRYOPRECIPITATE
BLOOD COMPONENT PREPARATION AND MONITORING
BLOOD GROUP SEROLOGY
GOOD MANUFACTORING PRACTICES IN BLOOD TRANSFUSION
BLOOD DONOR RECRUITMENT
CHALLENGES IN ACHIEVING 100% VOLUNTARY BLOOD DONATION
THE ‘RESTLESS LEGS SINDROM’: FIRST DATA OF A RESEARCH AMONG OUR DONORS
COMPARATIVE STUDY OF VOLUNTARY AND FAMILY REPLACEMENT BLOOD DONORS: SAFETY AND PROFILE
UNIVERSITY STUDENTS AND BLOOD DONATION
DONORS ‘AND NON-DONORS’ DISTANCE FROM VOLUNTARY BLOOD DONATION
THE FREQUENCY OF HPA-15 GENOTYPES IN POLISH POPULATION AND THE DETECTION OF HPA-15 ANTIBODIES IN FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA AND IN PATIENTS WITH PLATELET REFRACTORINESS
BLOCKADE OF MATERNAL ANTI-HPA-1A-MEDIATED PLATELET CLEARANCE BY AN HPA-1A EPITOPE-SPECIFIC F(AB)2 IN AN IN VIVO MOUSE MODEL OF ALLOIMMUNE THROMBOCYTOPENIA
KUWAIT NATIONAL ANTENATAL PROGRAM FOR RED CELL TYPING AND ANTIBODY SCREENING: 5 YEARS STUDY
EXCHANGE TRANSFUSIONS IN NEW-BORNS IN UPPSALA UNIVERSITY HOSPITAL 2001-MEDIO 2008
HAEMOVIGILANCE: RECENT ACHIEVEMENTS AND DEVELOPMENTS IN THE NEAR FUTURE
THE CANADIAN TRANSFUSION ERROR SURVEILLANCE SYSTEM (TESS): RESULTS FROM A THREE-YEAR PILOT PROJECT
INCORRECT BLOOD COMPONENTS TRANSFUSED IN AN ACADEMIC TRANSFUSION SERVICE IN THE LAST EIGHT YEARS
THE RESULTS OF LOOK BACK AND TRACE BACK PROCEDURES FOR HBV DNA POSITIVE/HBSAG NEGATIVE DONORS IDENTIFIED IN POLAND
HAEMOVIGILANCE IN NORDIC COUNTRIES: REPORT OF ADVERSE TRANSFUSION EVENTS 2007
HBV INFECTION IN THE MEDITERRANEAN BASIN AND EUROPE
HEPATITIS B VIRUS DNA AND SURFACE ANTIGEN PARTICLE CONCENTRATIONS IN EGYPTIAN BLOOD DONORS: LIMITS OF DETECTION OF ULTRA-SENSITIVE NUCLEIC ACID SCREENING TESTS IN HBSAG CARRIERS
POLYMORPHISM OF HEPATITIS B VIRUS FROM FIRST TIME BLOOD DONORS WITH HBSAG IN POLAND
A NEW HEPATITIS B VIRUS SUBTYPE D6 IN TUNISIAN BLOOD DONORS
OCCULT HEPATITIS B INFECTION IN BLOOD DONORS: A REAL PROBLEM
USE OF QUALITY TOOLS AND STATISTICAL TECHNIQUES FOR THE RESEARCH AND MANAGEMENT OF DAILY PROBLEMS IN A DEPARTMENT OF BLOOD DONATION AND TRANSFUSION
RESULTS OF AN ERROR-RISK-MANAGEMENT REPORTING SYSTEM (ERMS) AT THE RED CROSS BLOOD DONOR SERVICE BADEN-WÜRTTEMBERG-HESSEN IN 2007
ELIMINATION OF REDDISH FFP PROBLEM IN EGYPTIAN NATIONAL BLOOD TRANSFUSION SERVICES
FMEA IN TRANSFUSION RISK MANAGEMENT: EXPERIENCE IN A HOSPITAL-BASED TRANSFUSION SERVICE
OUTCOME AMONG RECIPIENTS OF PLASMA FROM FEMALE DONORS-A REGISTER-BASED COHORT STUDY
AUTOMATISATION IN THE SCREENING FOR DETECTION OF GRANULOCYTE ANTIBODIES WITH A NOVEL ASSAY
NT-PRO BNP AS A MARKER FOR DIFFERENTIAL DIAGNOSIS BETWEEN TRALI AND TACO
TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD (TACO): THE NEW NUMBER ONE KILLER REPORTED TO THE QUEBEC HEMOVIGILANCE SYSTEM
HEPATITIS C INFECTION: RECENT INSIGHTS RELEVANT TO TRANSFUSION SAFETY
ESTIMATION OF THE RISK OF HEPATITIS C VIRUS INFECTIOUS DONATIONS ENTERING THE BLOOD SUPPLY IN SHANGHAI, 2006-2007
THE IMPACT OF DIFFERENT HCV BLOOD SCREENING TECHNOLOGIES ON THE REDUCTION OF TRANSFUSION TRANSMITTED HCV INFECTION RISK IN EGYPT
EVALUATION OF THE ARCHITECT HCV ANTIGEN ASSAY FOR USE IN ORGAN AND TISSUE DONORS
GROWTH AND REPLICATION OF PLASMA-DERIVED HEPATITIS C VIRUS IN CELL CULTURE
BLOOD DONOR MANAGEMENT SYSTEM (BDMS)
DEVELOPING INTERFACE STANDARDS - FUTURE ISBT GUIDELINES
VALIDATION OF AUTOMATED SYSTEMS IN BLOOD ESTABLISHMENTS-ISBT GUIDELINE
RADIO FREQUENCY IDENTIFICATION (RFID) IN TRANSFUSION MEDICINE
D ANTIGEN VARIANTS IN THE ITALIAN POPULATION: THE ‘RAINBOW PROJECT’
SEROLOGICAL AND MOLECULAR CHARACTERIZATION OF D VARIANTS
RHD ANTIGEN EXPRESSION FROM THE CEAR ALLELE: AN RHD POSITIVE BLOOD DONOR NOT CARRYING THE DAR VARIANT USUALLY ASSOCIATED
MASS-SCALE GENOTYPING OF RBC DONORS IN THE BASQUE COUNTRY
BLOOD DONOR RECRUITMENT PROGRAM AT NATIONAL BLOOD TRANSFUSION SERVICES, EGYPT
THE ROLE OF SCHOOL TEACHERS TO SUPPORT BLOOD COLLECTION AND DONOR RETENTION AT SCHOOLS
THE SOCRATES COMENIUS PROJECT ‘VOLUNTARY WORK- BLOOD DONATION’ A TOOL FOR HEALTH EDUCATION IN SCHOOLS OF ROMANIA/TURKEY/GREECE - PROMOTION OF SOLIDARITY AND BLOOD DONATION IN STUDENTS AND CITIZENS
EVALUATION OF DONORS' SATISFACTION AS PART OF ANNUAL INTERNAL ASSESSMENT
THE BACTERIAL CONTAMINATION OF PAEDIATRIC WHOLE BLOOD TRANSFUSIONS IN A KENYAN HOSPITAL
EVALUATION OF THE BACT/ALERT AUTOMATED MICROBIAL DETECTION SYSTEM FOR THE SCREENING OF HAEMOPOIETIC PROGENITOR CELLS
INTRODUCTION OF BACTERIAL SCREENING OF PLATELETS IN AUSTRALIA; MANAGING THE CLINICAL IMPACT
AN OPTIMIZED REAL-TIME 16S RIBOSOMAL DNA POLYMERASE CHAIN REACTION ASSAY FOR BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES
A LABORATORY COMPARISON OF MIRASOL∩ PATHOGEN REDUCTION TECHNOLOGY TREATMENT AND CULTURE OF PLATELET PRODUCTS FOR ADDRESSING BACTERIAL CONTAMINATION CONCERNS
IMPACT OF BENCHMARKING ON BLOOD PRODUCT QUALITY AND ECONOMY IN BLOOD DONOR SERVICES
TEN-YEAR SURVIVAL FOLLOW-UP OF CARDIAC SURGERY PATIENTS AFTER LEUKOCYTE REDUCED BLOOD TRANSFUSION
INTRODUCTION OF OCTAPLAS∩ IN CLINICAL USE DECREASED THE RATE OF SEVERE ADVERSE REACTIONS
EFFECT OF THE IMMEDIATE AND DELAYED PLATELET STORAGE ADDITION ON THE PLATELET ACTIVATION MEASURED AS P-SELECTIN EXPRESSION
POSTOPERATIVE ANAEMIA AND QUALITY OF LIFE AFTER LOWER JOINT ARTHROPLASTY
PREVENTION OF TRANSFUSION ERRORS AT THE BEDSIDE
WHERE DO ALL THE PLATELETS GO? - HOSPITAL BASED AUDIT OF PLATELET TRANSFUSION IN TWO AUSTRALIAN STATES
GENERATION OF ERYTHROCYTIC CELLS FROM EMBRYONIC STEM CELLS IN SMALL SCALE AND MASS CULTURES
SIGNIFICANCE OF KIR2DL1 - HLA-CW GROUP2 AND KIR2DL2/3 - HLA-CW GROUP1 MISMATCHES FOR CLINICAL OUTCOME OF STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA
PLATELET-LIKE CELLS CAN BE GENERATED AT LARGE NUMBERS FROM CULTURED HUMAN CD34 + PROGENITOR CELLS, BUT DISPLAY RECIRCULATION INTO HEMATOPOIETIC TISSUE UPON TRANSFUSION IN MICE
EFFECTS OF PLATELET SUPERNATANT AND LYSATE ON EXPANSION AND DIFFERENTIATION OF UMBILICAL CORD BLOOD CD133+STEM CELLS TO MEGAKARYOCYTE PROGENITOR CELLS
BLOCKADE OF a6-INTEGRIN REVEALS DIVERSITY IN HOMING PATTERNS BETWEEN HUMAN AND MURINE CELLS
CLIMATE CHANGE AND VECTOR BORNE VIRAL DISEASES POTENTIALLY TRANSMITTED BY TRANSFUSION
SHIFTING THE FOCUS OF MALARIA DEFERRALS: TIME FOR A NEW PARADIGM
TRYPANOSOMA CRUZI DETECTION AND QUANTIFICATION BY REAL-TIME PCR
MOLECULAR POLYMORPHISM OF THE DRB1 ALLELES IN INFECTION WITH MYCOBACTERIUM LEPRAE AND TRYPANOSOMA CRUZI IN ROSARIO, ARGENTINA
THE TOP 10 PUBLICATIONS IMPACTING CLINICAL PRACTICE OF TRANSFUSION MEDICINE IN THE LAST 10 YEARS
THE IMPACT OF TRAINING IN TRANSFUSION MEDICINE
SYSTEMS FOR ACCREDITATION IN BLOOD TRANSFUSION SERVICES
OVERVIEW ON EGYPTIAN FELLOWSHIP BOARD TRANSFUSION MEDICINE
ADOPTION AND PERCEIVED OUTCOMES OF THE WHO BLOOD SAFETY DISTANCE LEARNING MATERIALS
TRANSFUSION OF TRAUMA VICTIMS - DOES INCREASING NUMBER OF PATIENTS OR NEW ALGORITHMS CHANGE THE WAY BLOOD PRODUCTS ARE USED?
INCREASED DEEP VEIN THROMBOSIS AND IN HOSPITAL MORTALITY WITH THE TRANSFUSION OF OLD RBCS FOR PATIENTS WITH TRAUMATIC INJURIES
TRANSFUSION OF PLASMADEPLETED PLATELET CONCENTRATES IN PREMATURE INFANTS AND NEWBORNS
3C-S18-05
NEW METHODS OF PLASMA FRACTIONATION - A PRESENTATION OF THE ‘MINI-POOL’ FRACTIONATION SYSTEM (MPFS) DEVELOPED IN EGYPT
ADVANCING THE PROCESSING TECHNIQUE OF CRYOPRECIPITATE
HAEMOLYTIC REACTIONS ASSOCIATED WITH THA ADMINISTRATION OF INTRAVENOUS IMMUNE GLOBULIN
TOLL-LIKE RECEPTOR 4 LIGAND CAN DIFFERENTIALLY MODULATE THE RELEASE OF CYTOKINES BY HUMAN PLATELETS
INTRA-VITAL FLUORESCENCE MICROSCOPY TO EVALUATE MITOCHONDRIAL POTENTIAL, CA2+ INPUT AS A STRESS MARKER AND CELL MEMBRANE INTEGRITY OF PLATELETS: QUALITY ASSESSMENT OF FUNCTIONAL CELLS
ENDOGLYCOSIDASE TREATMENT PREVENTS ANTBODY-MEDIATED CLEARANCE OF HUMAN PLATELET IN AN IN VIVO MODEL OF IMMUNE THROMBOCYTOPENIA
THE INFLUENCE OF MONOCLONAL ANTIBODIES FOR IMMOBILISATION OF GPIIB/IIIA IN QUANTITATIVE MAIPA: PREDICTIVE POTENTIALS AND CUT-OFF LEVELS FOR SEVERE THROMBOCYTOPENIA IN THE NEWBORN
EFFICACY OF DIFFERENT PLASMA SOURCES IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA
ABO/H HISTO-BLOOD GROUP ‘SERO-CONVERSION’ BY SIMPLIFIED IMMUNOADSORPTION AND THE USE OF ‘MULTI-MANNER’ APHERESIS IN RENAL TRANSPLANTS
CLINICAL EFFECTS OF CHRONIC RED BLOOD CELL EXCHANGE AND DIFFERENT TYPES OF RED CELL CONCENTRATES IN PATIENTS WITH SICKLE CELL DISEASE (SCD)
DOUBLE RED CELL COLLECTIONS WITH ALYX TO REDUCE PAIN IN SEVERE HAEMOCHROMATOSIS PATIENTS
SFAS LIGAND IN LEUKOREDUCED RED BLOOD CELLS AND PLATELETS FROM APHERESIS
PERFORMANCE EVALUATION OF NOVEL ANTISERA FOR RAPID ABO, RH SUBGROUP, AND K TYPING USING LATERAL FLOW TECHNIQUE (MD MULTICARD)
DNA ARRAY ANALYSIS FOR RED BLOOD CELL ANTIGENS FACILITATES THE TRANSFUSION SUPPORT WITH ANTIGEN-MATCHED BLOOD IN SICKLE CELL DISEASE PATIENTS
OXIDATIVE CLEAVAGE OF BAND 3 CYTOPLASMIC DOMAIN DURING RED BLOOD CELL STORAGE
IDENTIFICATION OF 16 NEW ALLELES AT THE FUCOSYLTRANSFERASE 1, 2 AND 3 LOCI IN STYRIAN BLOOD DONORS
EMERGING PATHOGENS AND POSSIBLE THREATS TO BLOOD SERVICES
THE OUTBREAK OF WEST NILE VIRUS INFECTION IN NORTHERN ITALY: AN ADDITIONAL NEW RISK FOR THE SAFETY OF BLOOD AND ORGAN DONATION
MINIPOOL NAT HIV-1 BREAKTHROUGH TRANSMISSION CASES AND PROBABILITY OF INTERDICTION BY CURRENT SMALL POOL OR INDIVIDUAL-DONATION NAT SCREENING SYSTEMS
HTLV-I/II PREVALENCE IN AT-RISK BLOOD DONORS FROM CENTRAL AND SOUTH AMERICA IN A NON-ENDEMIC AREA (CATALONIA, SPAIN)
INFECTIVITY OF B19 POSITIVE BLOOD PRODUCTS
INTEGRATION OF BLOOD TRANSFUSION SERVICES [BTS] INTO NATIONAL HEALTH SYSTEM, EGYPT EXPERIENCE
THE ROLE OF HOSPITAL BLOOD BANKS: EQUIPMENT AND PROCEDURES FOR BLOOD SAFTY IMPROVEMENT
CHANGE CONTROL IN CROATIAN INSTITUTE OF TRANSFUSION MEDICINE (CITM) 2000-2007
EUROPEAN HARMONISATION OF TRANSFUSION PRACTICE: THE EQUAL BLOOD SOP-MANUAL GIVING GUIDELINES FOR QUALITY MANAGEMENT AND PROCESS DOCUMENTATION
EFFECT OF IMPLEMENTING AUB IN PILOT PROGRAMME OF SWISS EGYPTIAN PROJECT (GHARBIA RBTC AND GOVERNMENTAL HOSPITALS BLOOD BANKS) ON BLOOD UTILIZATION
INTERNATIONAL RARE BLOOD DONOR CENTER
BLOOD-DERIVED BIOMATERIALS: FIBRIN SEALANT, PLATELET GEL AND PLATELET FIBRIN GLUE
PROTEOMICS AND BLOOD TRANSFUSION.
FAINT AND PREFAINT REACTIONS IN WHOLE BLOOD DONORS: PREDICTIVE VALUE OF PRE-DONATION MEASUREMENTS
THE SPECTRUM OF ADVERSE REACTIONS FOLLOWING DOUBLE RED CELL (R2) APHERESIS DONATIONS FAVORS USE IN YOUNG DONORS
HAEMOVIGILANCE IN NORDIC COUNTRIES: REPORT OF DONOR COMPLICATIONS 2007
DONOR RETURN RATE IS RELATED TO ADVERSE EVENTS OCCURRING DURING BLOOD DONATION
PREDICTING THE OCCURRENCE OF VASOVAGAL REACTIONS IN BLOOD DONORS: A QUESTIONNAIRE STUDY BY THE KANAGAWA RED CROSS BLOOD CENTER
PATHOGEN REDUCTION METHODS: ADVANTAGES AND LIMITS
IMPACT OF PATHOGEN REDUCTION TECHNOLOGY (PRT) WITH MIRASOL∩ AND STORAGE IN PLATELET ADDITIVE SOLUTIONS (PAS) ON PLATELET FUNCTION
A TWO-YEAR EXPERIENCE OF TRANSFUSING PLATELET COMPONENTS PREPARED WITH INTERCEPT PATHOGEN INACTIVATION SYSTEM AND STORED FOR UP TO 7 DAYS
FROZEN RED CELLS, PLASMA AND PLATELETS IN COMBAT CASUALTY CARE
EGYPTIAN NATIONAL BLOOD TRANSFUSION SERVICES CONVERSION PLAN
AUDITS OF REGIONAL BLOOD BANKS IN MORROCO A TOOL FOR IMPROVEMENT
TRANSFORMATION OF BLOOD TRANSFUSION SYSTEM IN R.MACEDONIA-A STEP TOWARDS BLOOD SAFETY
CURRENT SITUATION WITH THE BLOOD TRANSFUSION SERVICE IN R. MACEDONIA
THE METHOD OF THE BLOOD CRISIS POLICY IN THE CZECH REPUBLIC
THE SETTING OF A QUALITY PROCESS IN BLOOD TRANSFUSION CENTER OF OUJDA
SETTING UP A QUALITY ASSURANCE SYSTEM IN ORAN ALGERIA
P-008
SPECIAL PROCESSING ON BLOOD COMPONENTS
STUDY OF PRESENT INFRASTRUCTURE SYSTEMS IN IRANIAN BLOOD TRANSFUSION ORGANIZATION (IBTO) CENTERS
RESEARCH PRIORITIES FOR TRANSFUSION SERVICES IN SUB-SAHARAN AFRICA: MOMBASA CONSENSUS MEETING. SEPTEMBER 2008
DEVELOPMENT OF A NATIONAL SURVEILLANCE PROGRAM BASED ON SENTINEL HOSPITALS FOR THE MONITORING OF USAGE AND INVENTORY LEVELS OF BLOOD PRODUCTS IN KOREA
IMPLEMENTATION OF DOCUMENT CONTROL SYSTEM ACROSS NATIONAL BLOOD TRANSFUSION SERVICES
HEATH CARE REFORM IN SERBIA
CORRELATION IN BLOOD DONATION IN INSTITUTE FOR TRANSFUSION MEDICINE (ITM) IN SKOPJE - MACEDONIA
DIACHRONIC SURVEY FOR USE OF BLOOD PRODUCTS ON KARPENISI HOSPITAL
ETHICAL ISSUES IN BLOOD TRANSFUSION
UNIQUE MODEL OF CONVERTING BLOOD TRANSFUSION PRACTICE IN ALEXANDRIA INTO THE CENTRALIZATION MODEL AS A PART OF EGYPT NATIONAL CONVERSION PLAN
QUALITY AND SAFETY ASPECTS OF BLOOD COMPONENTS RELATED TO THE EUROPEAN BLOOD DIRECTIVES AND THE PUBLIC HEALTH PROGRAMME OF THE EUROPEAN COMMISSION
BLOOD USE IN INJURY CASES IN EGYPT
ESTABLISHMENT OF A NATIONAL BLOOD TRANSFUSION SERVICE IN PAKISTAN
EVALUATION OF COMPUTERIZED ON-LINE DONOR PROCESSING SYSTEM ON ERROR, DEFERRAL RATE AND DONOR SATISFACTION IN ESFAHAN, 2005
TRIMA ACCEL REPORTER: A NOVEL SOFTWARE TO CAPTURE THE PROCEDURE DATA FROM TRIMA ACCEL
ITIL IMPLEMENTATION IN TRASNFUSION SERVICE: AN EXAMPLE
P-025
INFORMATION TECHNOLOGY SYSTEM IN BLOOD TRANSFUSION DEPARTMENT OF GENERAL HOSPITAL DUBROVNIK - FOUR YEARS REVIEW
THE ROLE OF IT IN BLOOD BANKS
EGYPTIAN NATIONAL BLOOD TRANSFUSION SERVICES PROLONGED WAITING TIME FOR ISSUING BLOOD
A MODEL TO ACCOUNT FOR THE COST OF BLOOD IN A HOSPITAL
RISK MANAGEMENT IN TRANSFUSION MEDICINE-A PROACTIVE PROGRAM
COST EFFECTIVENESS OF IMPLEMENTATION OF QUALITY MANAGEMENT SYSTEM2
COSTING OF LABILE BLOOD PRODUCTS IN NBTC TUNIS TUNISIA
AN AUDIT ON NEAR - MISS EVENT IN TRANSFUSION MEDICINE UNIT, HOSPITAL UNIVERSITI SAINS MALAYSIA
IMPROVING THE QUALITY SYSTEM BY ROOT CAUSE ANALYSIS OF ALL EGYPTIAN NATIONAL BLOOD TRANSFUSION CENTER ERROR REPORTS
QUALITY PROCEDURE IN BLOOD TRANSFUSION IN MOROCCO
CUSTOMER SATISFACTION SURVEYS-AN IMPORTANT TOOL FOR PERFORMANCE IMPROVEMENT
NEED FOR EXCLUSIVE TRANING OF TECHNOLOGISTS AFTER DMLT IN TRANSFUSION MEDICINE
TRAINING AS A FOUNDATION FOR A STRATEGIC PLAN IMPLEMENTATION
RECRUITMENT OF NEW PHYSICIANS IN 3-DAY ASSESSMENT [EGYPTIAN EXPERIENCE],
OVERVIEW ON EGYPTIAN NBTS H R
ANTI-HBC SCREENING IN EGYPTIAN BLOOD DONORS REDUCES THE RISK OF HEPATITIS B VIRUS TRANSMISSION
RETAINING OF ANTI-HBC POSITIVE DONATIONS USING HBV-DNA IN KUWAIT CENTRAL BLOOD BANK
FOUR YEARS EXPERIENCE WITH ID NAT TESTING IN BLOOD DONATIONS IN SOUTHWESTERN GREECE
SURVEY OF ANTI-HBC AND ANTI-HBS PREVALANCE IN HBSAG NEGATIVE BLOOD DONORS IN TEHRAN
INTEREST OF DOSAGE AMINOTRANSFERASE ALT AMONG THE BLOOD DONORS IN EASTERN MORROCCO
HEPATITIS B: SEROLOGICAL MARKERS AND HBV NAT IN TRANSFUSION SAFETY
HEPATITIS B: RESIDUAL RISK REDUCTION AND IMPROVEMENT OF BLOOD TRANSFUSION SAFETY BY NAT TEST
DETECTION OF ONE PERIODIC DONOR NAT HBV DNA POSITIVE/HBSAG NEGATIVE IN SINGLE BLOOD DONATION
THE HIGHLY SENSITIVE ENZYME IMMUNOASSAY FOR HBSAG DETECTION AS THE ALTERNATIVE METHOD TO NAT TESTING
DETECTION OF TWO HEPATITIS B ASYMPTOMATIC CASES IN A POPULATION OF REPEAT DONORS IN ITALY
PHOTOCHEMICAL INACTIVATION OF HUMAN HEPATITIS B VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM AS MEASURED BY PCR
HBV DNA DETECTION ON HBSAG NON-REACTIVE/ANTI HBC REACTIVE DONATION SAMPLES
HIGH SEROPREVALENCE OF HBAG AMONG THE BLOOD DONORS IS THE LEADING CAUSE OF BLOOD DISCARD
GENOTYPE ANALYSIS OF HBV AND HDV IN TEHRAN, IRAN
HBV GENOTYPES IN BLOOD DONORS OF LISBON REGIONAL BLOOD CENTRE
GENOTYPING AND PHYLOGENETIC ANALYSIS OF THE POLYMERASE GENE OF HBV IN VOLUNTEER BLOOD DONORS IN IRAN
INITIALLY REACTIVE NAT SAMPLES OF DONORS WITH LOW HBV DNA LOAD AND ANTI-HBC REACTIVITY: DETECTION BASED ON COMBINATION BETWEEN COMMERCIAL AND IN-HOUSE PCR ASSAYS
PREVALENCE OF OCCULT HEPATITIS B (OBI) IN THALASSAEMIC PATIENTS IN GREECE: A MULTI-CENTRE RETROSPECTIVE STUDY
POSITIVE MARKERS OF TRANSMISSIVE DISEASES IN BLOOD DONORS IN INSTITUTE OF NEPHROLOGY IN STRUGA
SPECIFICITY OF ARCHITECT ANTI-HBC II ASSAY IN COMPARISON TO PRISM HBCORE ASSAY IN PORTUGUESE BLOOD DONORS
TRASMITTED TRANSFUSED VIRAL INFECTIONS AMONG BLOOD DONORS DURING YEARS 2006 AND 2007 IN SUEZ CANAL AREA, EGYPT
MOLECULAR EPIDEMIOLOGY OF HBV IN PORTUGAL
INVESTIGATION OF HBV SEROLOGICAL MARKERS, IN PARTICULAR ANTI-HBC TO FIND OUT THE FREQUENCY OF OCCULT HEPATITIS B INFECTION (OBI) AMONG 5059 VOLUNTARY BLOOD DONORS IN MASHHAD, IRAN
REPRESENTATION OF HBSAG AMONG BLOOD DONORS IN THE MUNICIPALITY OF KUMANOVO
OVERALL REPRESENTATION OF NAT RESULTS AND CORRELATION OF NAT NEGATIVITY WITH SEROPOSITIVE BLOOD DONORS
A SIMPLE TEST TO CONFIRM THE INITIALLY REACTIVE HBV DNA RESULT IN HBSAG NEGATIVE SUBJECTS IN BLOOD SCREENING
HBV ID-NAT RESULTS IN HBSAG POSITIVE BLOOD DONATIONS
LIVING WITH NAT: OUR EXPERIENCE AT KING KHALID NATIONAL GUARD HOSPITAL, JEDDHA, SAUDI ARABIA
MOLECULAR SCREENING OF HCV RNA AMONG ANTI HCV NEGATIVE AHWAZ BLOOD DONORS
HCV SCREENING OF DONORS IN GOVERNMENTAL BLOOD TRANSFUSION CENTERS AT MENOUFIA GOVERNORATE (FROM JAN. 2008 TO OCT. 2008)
ANALYTICAL AND TECHNICAL PERFORMANCES EVALUATION ON PROCLEIX TIGRIS SYSTEM FOR NAT SCREENING IN ITALY
SCREENING OF BLOOD DONORS BY MULTIPLEX NUCLEIC ACID AMPLIFICATION TECHNOLOGY (NAT) REDUCES THE RISK OF TRANSMISSION OF HEPATITIS B AND C IN EGYPT
THE PREVALENCE OF ANTI-HCV POSITIVE IN BLOOD DONORS IN CLINIC HOSPITAL-TETOVO
RESULTS OF TESTING OF CONFIRMED POSITIVE VOLUNTARY BLOOD DONORS TO HEPATITIS C MARKERS-TWO YEARS EXPERIENCE
THE CONSTRIBUTION OF PCR TO DETERMINE THE ANTI-HCV POSITIVE BLOOD DONORS AND RIBA NEGATIVE OR INDETERMINATE
IMPACT OF INDIVIDUAL BLOOD DONOR NUCLEIC ACID (NAT) IN APOLLO GROUP OF HOSPITALS & ITS EFFECT ON NEED FOR SAFER BLOOD IN INDIA
ANALYSIS OF HEPATITIS B AND C MARKERS TESTING IN VOLUNTARY BLOOD DONORS-10 YEARS SURVEY
DETERMINATION OF SIGNAL -TO- CUTOFF VALUE OF ANTI - HEPATITIS C VIRUS ENZYME IMMUNOASSAYS IN SCREENING OF BLOOD DONORS IN HOSPITAL UNIVERSITI SAINS MALAYSIA
HEPATITIS C VIRUS PREVALENCE AND CLEARANCE AMONG U.S. BLOOD DONORS, 2006-2007: ASSOCIATIONS WITH BIRTH COHORT, MULTIPLE PREGNANCIES AND BODY MASS INDEX
EXPERIENCE IN NAT SCREENING: COMPARISON OF PCR AND TMA BASED SYSTEMS
HLA DRB1 ALLELES IN PATIENTS WITH AUTOIMMUNE HEPATITIS
HEPATITIS C VIRUS INFECTION AND ITS GENOTYPES IN BLOOD DONORS IN IRAN
THE NAT/PCR BLOOD DONORS TESTING EXPERIENCE
EVALUATION OF IMMUNOASSAYS FOR HEPATITIS C VIRUS ANTIGEN AND ANTIBODY COMBINED DETECTION IN REACTIVE SERUM SAMPLES AMONG BLOOD DONORS
COMPARATIVE CLINICAL EVALUATION OF THE COBAS TAQSCREEN MPX TEST WITH THE COBAS AMPLISCREEN HIV-1 V1.5, HCV V2.0, AND HBV TESTS USING HIGH RISK POPULATION AND SEROPOSITIVE SPECIMENS
BACTERIAL CONTAMINATION RESIDUAL RISKS AND MITIGATIONS AT THE KUWAIT CENTRAL BLOOD BANK
PH TESTING FOR BACTERIAL CONTAMINATION OF PLATELET CONENTRATES IN JEDDAH, SAUDI ARABIA
MICROBIOLOGICAL CONTROL OF PERSONNEL HANDSSWAB OR FINGER PRINTS
MINIMIZING THE RISK OF SEPSIS: INLET LINE SAMPLE DIVERSION AND INCREASED SAMPLE VOLUME REDUCE PLATELET CONTAMINATION AND IMPROVE BACTERIAL CULTURE SENSITIVITY
RETESTING OSLO BLOOD DONORS FOR SYPHILIS
FINDING THE BUGS IN PLATELETS - BACTERIAL CONTAMINATION SCREENING IN AUSTRALIA
THE STUDY OF EFFICIENCY OF GMP FOR PHLEBOTOMY IN DECREASING THE RATE OF BACTERIAL CONTAMINATION OF PLATELET UNITS PRODUCED IN TEHRAN BLOOD TRANSFUSION CENTER BY USING BACT/ALERT
THE USE OF THE BACT/ALERT SYSTEM FOR SCREENING CORD BLOOD DONATIONS
STERILITY TESTING OF BLOOD COMPONENTS
MACOPLAS LYOPHILIZED PLASMA: BACTERIAL FILTER TESTING OF TWO PLASMA FILTERS
CHAGAS' DISEASE IN ARGENTINA: SEROPREVALENCE IN BLOOD DONORS AND EVALUATION OF AN ELISA ASSAY FOR ANTIBODY DETECTION
DESCRIPTIVE STUDY OF POLYMORPHISMS ENOS (G894T) AND OXIDATIVE STRESS IN PATIENTS CHAGAS DISEASE, WITH AND WITHOUT CARDIOPATHY
BETAMETHASONE CAN REACTIVE TOXOPLASMOSIS IN BLOOD AND THE INFECTION DETECTABLE BY USING ELISA AND PCR
CLINICAL PERFORMANCE OF THE ABBOTT PRISM CHAGAS ASSAY
EFFECT OF ASCARIS LUMBRICOIDES ON THE ERYTHROCYTE SUPERFICIAL CHARGE USING PARTITION METHOD IN AQUEOUS TWO-PHASE SYSTEM
ANTI T. CRUZI PREVALENCE IN BLOOD DONORS AT THE REGIONAL CENTRE OF LA PLATA CITY, ARGENTINA
PREVALENCE OF INFECTIOS MARKERS IN BLOOD DONOR POPULATION IN TIRANA
EVALUATION OF CORRELATION IN BLOOD DONORS' REJECTION AND TREND OF VIRAL MARKERS FROM 2004 TO 2007, ISFAHAN, IRAN
DECREASING THE RISK OF TRANSFUSION TRANSMITTED INFECTIONS (TTIS) IN THE EGYPTIAN BLOOD TRANSFUSION SERVICES
EVALUATION STUDY OF TWO COMMERCIAL KITS FOR DETECTION OF CMV DNA
PREVALENCE OF HIV IN BLOOD DONORS IN THE DEPARTEMENT OF SIDI BEL ABBES IN THE DEMOCRATIC AND POPULAR ALGERIAN REPUBLIC
HTLV I/II WESTERN BLOT ASSAY AS A COMPLEMENTARY TEST FOR DONOR's FOLOW UP AND COUNSELLING
EXPERIENCE WITH USAGE OF OPTIQUANT EBV DNA QUANTIFICATION PANEL IN EVALUATION STUDY FOR TWO COMMERCIAL KITS
CALIBRATION OF ANALYTICAL STANDARDS FOR HBV-DNA, HCV-RNA AND HIV-1 RNA IN GENOME COPIES BY A REFERRENCE METHOD
EPIDEMIOLOGY OF TRANSFUSION-TRANSMITTED INFECTIONS IN MULTI TRANSFUSED PATIENTS IN ABANIA
PREVALENCE OF HCV AND HBV INFECTIONS AMONG BLOOD DONORS IN DAKAHILIA, EGYPT
THE INCIDENCE AND TRENDS OF HBSAG, ANTI HCV, ANTI HIV I & II, ANTI BODIES TO TREPONEMA PALLIDUM AND SLIDE TEST FOR MALARIA PARASITE IN SRI LANKAN BLOOD DONATIONS
FOUR PARAMETER NAT SCREENING BY TAQSCREEN MPX WITH COBAS S201 IN SWITZERLAND: VALIDATION, IMPLEMENTATION AND FIRST EXPERIENCES
POLYMORPHISM AND EXTREMELY HIGH VIRAEMIA OBSERVED IN PARVOVIRUS B19 DIAGNOSTIC SAMPLES - POTENTIAL DIFFICULTIES THAT COULD BE FACED DURING B19 SCREENING IN BLOOD DONORS
EVALUATION OF INITIALLY REACTIVE (IR) NAT-TMA RESULTS. IMPACT ON BLOOD TRANSFUSION SAFETY
AUTOMATION OF A NEW VIRONOSTIKA HIV AG/AB SCREENING ASSAY USING THE DAVINCI PLATFORM
SETTING STATISTICAL TEST SIGNIFICANCE LEVELS WHEN APPLYING INCIDENCE MONITORING TOOLS
PREVALENCE OF ANTI-HTLV-I/II IN SLOVENIAN BLOOD DONORS AND THE IMPACT ON BLOOD SCREENING
THE PREVALENCE OF HTLVI-II IN BLOOD DONORS DURING A 5 YEARS PERIOD
RELEVANCE OF SCREENING ASSAY SENSITIVITY IN IDENTIFYING WINDOW PERIOD INFECTIONS IN BLOOD DONORS
EVALUATION OF TTIS SCREENING ASSAYS EGYPTIAN EXPERIANCE
THE PREVALENCE OF HIV, VHB, VHC AND SYPHILIS SEROLOGICAL MARKERS IN BLOOD DONORS AT THE CRTSO (1996-2007)
FIVE YEARS EXPERIENCE OF NAT INDIVIDUAL DONATION IN LISBON REGIONAL BLOOD CENTRE DONORS
PERFORMANCE EVALUATION OF A NEW FULLY AUTOMATED HTLV-I/HTLV-II ASSAY IN PORTUGUESE BLOOD DONORS
REAL-TIME PCR ASSAY COMPARED WITH ANTIGENEMIA ASSAY FOR DETECTING CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT PATIENTS
DECLINING TENDENCY OF HUMAN T-CELL LEUKEMIA VIRUSTYPE I CARRIER RATES AMONG BLOOD DONORS IN MASHHAD, IRAN
IMPACT OF INDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT) ON THE RESIDUAL HIV TRANSMISSION RISK OF SOUTH AFRICAN BLOOD TRANSFUSIONS: THREE YEAR EXPERIENCE
ANTIBODIES TO HIV 1 + 2 IN BLOOD DONORS FROM SOUTH-EASTERN SERBIA
COMBINED HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN-ANTIBODY ASSAY INVESTIGATION AMONG BLOOD DONORS IN SERBIA
A COMBINATION FILTER FOR PRION AND LEUKOCYTE REDUCTION, ITS PRION REDUCTION PERFORMANCE IN SPIKING TEST ASSESSED BY BIOASSAY
BLOOD SAFETY AND DEFERRED DONORS
RECRUITMENT OF VNRBD IN KUWAIT: TWO YEARS EXPERIENCE
THE POWER OF MEDIA CAMPAIGNS IN PROMOTING VNRBD CULTURE IN THE COMMUNITY
MOBILE UNITS COLLECTION: PRELIMINARY ANALYSIS
AUTOMATED PLATELET DONATION: HOW SAFE IS SAFE
AUTOLOGOUS BLOOD TRANSFUSION IN ZARIA, NIGERIA
THE INFLUENCE OF DIFFERENT PROCESSING CONDITIONS ON IN VITRO QUALITY OF RED BLOOD CELLS COLLECTED WITH THE ALYX COMPONENT COLLECTION SYSTEM AND NEW ADDITIVE SOLUTION
BLOOD DONATION IN NATIONAL INSTITUTE FOR TRANSFUSION MEDICINE-SKOPJE, MACEDONIA IN THE PERIOD 2002-2007
CORD BLOOD COLLECTION: SIGNIFICANCE OF MATERNITY HOSPITAL PERSONNEL TRAINING
FOLLOW UP OF HEMOGLOBIN AND FERRITIN IN REPEAT DONORS GIVING EITHER APHERESIS DOUBLE RED CELL CONCENTRATES WITH ALYX COMPONENT COLLECTION SYSTEM OR WHOLE BLOOD
THE MOBILE BLOOD COLLECTION IN ORAN: STATE OF PLAY
PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN POLAND
HOW AUTOMATED RED BLOOD CELL COLLECTIONS CAN ADDRESS CURRENT BLOOD BANKING CHALLENGES. THE FRENCH EXPERIENCE
DETERMINATION OF PERIODICAL VARIATION IN BLOOD DONATION-FACTOR TO ACHIEVE CONTINUITY IN BLOOD DONATION
IRON STATUS AND APHERESIS DONATION OF DOUBLE DOSE RED CELLS
REVIEW OF BLOOD DONATIONS IN BTI NOVI SAD DURING THE PERIOD OF 40 YEARS
MOBILE BLOOD DONATION REGISTRATION SERVICE: AN EXPERIENCE
SOCIAL MARKETING TOOLS TO IMPROVE BLOOD COLLECTION AND DONOR RETENTION
IMPORTANCE AND RESULTS OF EDUCATIONAL-MOTIVATIONAL WORK WITH VOLUNTARY BLOOD DONORS AMONG SECONDARY SCHOOL AND UNIVERSITY STUDENTS
WE DO NOT NEED TOO MUCH BLOOD-IS THERE IS A NEED TO BE INVOLVED INTO BLOOD DONOR MOTIVATION AND RECRUITMAN OF BLOOD DONORS
DEVELOPMENT OF A BLOOD COLLECTION COMMITTEE IN THE NATIONAL BLOOD TRANSFUSION SERVICES IN EGYPT
NAT SCREENING IN TISSUE AND ORGAN DONORS
RETROSPECTIVE ANYLYSIS OF BLOOD DONOR TURNOUT FOR MOBILE BLOOD DONATION PROGRAMMES IN NATIONAL BLOOD CENTRE, SRI LANKA
FINAL RESULTS OF THE FRENCH MULTICENTER DONOR SATISFACTION EVALUATION AFTER A COLLECTION OF TWO RED BLOOD CELL UNITS
DONOR RED CELL APHERESIS WITH ALYX COMPONENT COLLECTION SYSTEM
VOLUNTARY, NON-REMUNERATED BLOOD DONATION: HOW TO APPROACH YOUNG PEOPLE
SELF-SUFFICIENCY OF BLOOD AND HEMOCOMPONENTS IN LOMBARDY: THE CONTRIBUTION OF AVIS (ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION) REGIONALE
BLOOD DONORS AMONG THE EMPLOYEES IN THE GENERAL HOSPITAL- STRUMICA,R.MACEDONIA
COLLECTION TARGET TO COMPLETE CENTRALIZATION OF BLOOD COLLECTION IN EGYPT
BLOOD DONORS AND ETHNIC CORRELATION
DONOR CHARACTERISTICS EVALUATED IN A FELICITATION PROGRAM
CHARACTERISTICS OF DONORS IN RELATION TO STAGNATION OF LEUKOCYTE FILTRATION
SCREENING FOR PROSTATE CANCER IN ASYMPTOMATIC BLOOD DONORS USING PSA ASSAY: OUR EXPERIENCE
INVESTIGATION OF THE FIRST TIME VOLUNTARY BLOOD DONORS' SATISFACTION - EXPERIENCE OF THE BLOOD TRANSFUSION INSTITUTE OF SERBIA
WHY I AM A BLOOD DONOR
VALIDITY OF HEMOGLOBIN COLOR SCALE IN BLOOD DONOR SCREENING BASED ON STANDARD OPERATION PROCEDURES (SOP) OF IRANIAN BLOOD TRANSFUSION ORGANIZATION
THE INFLUENCE OF THE CONCENTRATION OF HEAVY METALS IN THE BLOOD OF MINERS-BLOOD DONORS IN THE MUNICIPALITY OF PROBISTIP
EFFECT OF NATIONAL DISASTER ON BLOOD SUPPLY AND SAFETY AFTER BAM'S EARTHQUAKE
UNDERSTANDING STUDENT MOTIVATIONS AND BELIEFS ABOUT BLOOD DONATION
IMPACT OF DEMOGRAPHIC CHANGES ON THE BLOOD SUPPLY
COMPARISON OF CAPILLARY & VENOUS HAEMOGLOBIN (HB) LEVELS IN BLOOD DONORS IN INDIA.
INCIDENTS OF HEPATITIS B AMONG REPEAT VOLUNTEER AND REPLACEMENT BLOOD DONORS
CHARACTERISTICS, INFORMING AND MOTIVES OF BLOOD DONOR VOLUNTEER
MOST COMMON CAUSES OF BLOOD DONOR's EXCLUSION
TEMPORARY BLOOD DONOR DEFERRALS DUE TO LOW HEMOGLOBIN LEVELS IN POLISH REGIONAL BLOOD CENTERS
THE DELAYED DONATION: THE EXPERIENCE OF AVIS REGIONALE LOMBARDIA
BLOOD GROUP DISTRIBUTION AMONG BLOOD DONORS-MACEDONIANS AND ROMANY (GYPSIES) WITHIN A THREE-YEAR PERIOD (2005-2007) AT THE TRANSFUSION DEPARTMENT IN THE GENERAL HOSPITAL-STRUMICA
TWO DAYS OFF-A MOTIVE TO DONATE BLOOD OR NOT?
CHARACTERISTICS OF BLOOD DONORS IN DEPARTMENT OF TRANSFUSIOLOGY, GENERAL HOSPITAL-STRUMICA, REPUBLIC OF MACEDONIA
CHARACTERISTICS OF BLOOD DONORS IN THE DEPARTMENT OF TRANSFUSIOLOGY, GENERAL HOSPITAL-STRUMICA, REPUBLIC OF MACEDONIA
FERRITIN SERUM LEVELS IN BLOOD DONORS POPULATION
B12 AND FOLATE ACID SERUM LEVELS IN BLOOD DONORS POPULATION
IRON DEFICIENCY IN REPEATED BLOOD DONORS IN WU TRANSFFUSIOLOGY AT GENERAL HOSPITAL IN STIP
ADVERSE REACTION OF BLOOD TRANSFUSION
ADVERSE REACTIONS IN 106,082 BLOOD DONATIONS
ADVERSE EVENTS OF BLOOD DONATION IN 2386 FIRST DONORS
ADVERSE REACTIONS IN BLOOD DONORS: A MULTICENTRIC EXPERIENCE IN ITALY
ADVERSE REACTIONS IN WHOLE BLOOD AND AUTOMATED 2-UNIT RED CELL DONATIONS AMONG 2RBC-ELIGIBLE ALLOGENEIC MALE DONORS: A MULTIVARIATE ANALYSIS
OVERVIEW OF VASOVAGAL REACTIONS FOLLOWING WHOLE BLOOD DONATION: AN EXPERIENCE FROM A SINGLE GREEK BLOOD BANK
UNWANTED REACTIONS ON VOLONTERI BLOOD DONORS OUR EXPERIENCE
RECORDING OF SIDE EFFECTS AT THE DURATION OF BLOOD DONATION
LOOK BACK PROGRAMME FOR HIV SEROPOSITIVE BLOOD DONORS IN HELLAS
ACUTE MANAGEMENT OF COMMON ADVERSE REACTIONS IN A MASS IN-HOUSE BLOOD DONATION DRIVE IN SRI LANKA
FETAL RHESUS D GENOTYPING BY PCR USING PLASMA FROM RHD NEGATIVE PREGNANT WOMEN
FETOMATERNAL HEMORRHAGE: SCREENING AND QUANTIFICATION AT A TERTIARY CARE CENTER IN SAUDI ARABIA
FATAL HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) POSSIBLY DUE TO ANTI-JRa
COMPARISON OF LIPOFECTAMINE2000 AND FUGEN6 EFFICIENCY IN THE TRANSFECTION OF SPLEEN DERIVED DENDRITIC CELLSWITH SIRNA AGAINST CD40 MRNA
P-197
ABO AND RH (D) BLOOD GROUP DISTRIBUTION AMONG BLOOD DONORS AND BLOOD RECIPIENTS AT NATIONAL BLOOD CENTER SRI LANKA
IMMUNE MODULATION BY SILENCING CD40 EXPRESSION IN DENDRITIC CELLS USING SMALL INTERFERINGRNA
LONG-TERM TRANSFUSION ASSOCIATED MICROCHIMERISM (TA-MC) IN A PROSPECTIVE STUDY
CLINICALY SIGNIFICANT RED CELL ANTIBODY IN PREGNANT WOMEN - TWENTY-FIVE YEARS-LONG EXPERIENCE
RARE CASES OF SENSIBILIZATION ACCORDING TO RH-HR SYSTEM
DETERMINATION OF BLOOD GROUPS ABO AND RH (D) SYSTEM IN VOLUNTARY BLOOD DONORS
MULTIPLE INTRAUTERINE TRANSFUSIONS IN A PREGNANT WOMAN ALLOIMMUNIZED BY ANTI-C, -D, -E, - JKA, WITH SEVERE HEMOLYTIC DISEASE OF THE NEWBORN
INMUNOHEMATOLOGICAL CONTROL POST Rh (D) IMMUNE GLOBULIN PROPHYLAXIS
ASSOCIATION BETWEEN NEONATAL ANAEMIA AND HYPERBILIRUBINEMIA WITH RH-ALLOIMMUNIZED PREGNANCIES: CASE CONTROL STUDY
PROSPECTIVE EVALUATION OF THE CLINICAL USEFULNESS OF ANTIGEN BINDING ASSAYS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
CD36 (PLATELET GLYCOPROTEIN IV) AND ICAM-1: ESTABLISHING THE RANGE OF EXPRESSION OF HOST CYTOADHESION LIGANDS BY FLOW CYTOMETRY OF MONOCYTES AND PLATELETS IN PLASMODIUM FALCIPARUM MALARIA INFECTION
PROGNOSIS OF HEMOTRANSFUSION EFFECT AT POSTTRANSFUSION PURPURA
HLA TYPING AMONG APHERESIS DONORS IN THE NATIONAL BLOOD CENTRE, KUALA LUMPUR
PLATELET RICH PLASMA SUPPRESS EX VIVO EXPANSION OF MEGAKARYOCYTE PROGENITORS FROM CORD BLOOD
PRIMARY AUTOIMMUNE NEUTROPENIA IN CHILDREN IN TAIWAN
THE TREATMENT OF ESSENTIAL THROMBOCYTHAEMIA
CASE OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY ANTIBODIES AGAINST HPA-3A
HA-1 (MINOR HISTOCOMPATIBILITY ANTIGEN) DISPARITY AND THE ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
THE HUMAN PLATELET ANTIGEN (HPA) SYSTEM OF 1 THROUGH 7 GENOTYPE AND ALLELE FREQUENCIES BY PCR-SSP IN DONORS IN CHINESE CANTONESE
HLA CLASS I ANTIGEN EXHANGE BETWEEN PLASMA AND PLATELETS - AN EVALUATION OF PLATELET APHAERESIS CONCENTRATES DURING STORAGE FOR 4 DAYS
IMPLEMENTATION OF A NATIONAL EQAS OF RED CELL SEROLOGY IN EGYPTIAN NBTS; A ONE YEAR TRIAL
RED CELL ALLO- IMMUNIZATION IN REGULARLY TRANSFUSED EGYPTIAN PATIENTS
FREQUENCY OF RH PHENOTYPES AMONG EGYPTIAN POPULATION
IMPROVEMENT OF QUALITY IN PRETRANSFUSION TESTING IN BLOOD TRANSFUSION INSTITUTE NIS, SOUTH SERBIA
LOSS OF A, B, AND H ANTIGENS IN ORAL CANCER
ABO AND RHEZUS D BLOOD GROUPS DISTRIBUTION IN ALBANIAN POPULATION
DETERMINATION OF 24 MINOR RED BLOOD CELL ANTIGENS FOR CORD BLOOD CELLS BY HIGH-THROUGHPUT DNA ANALYSIS
MOLECULAR ANALYSIS OF FY AND RH ALLELES IN THE POPULATION OF ROSARIO, ARGENTINA
ASSOCIATION OF THE ONSET OF SEVERE AUTOIMMUNE HEMOLYTIC ANEMIA, AND PARTIAL REMISSION OF IMMUNE THROMBOCYTOPENIC PURPURA, FOLLOWING VACCINATIONS GIVEN IN PREPARATION FOR SPLENECTOMY
DETERMINATION OF ERYTHROCYTE-BOUND IGG TO MEMBRANE AS MARKERS OF CELL AGE
THE USE OF AUTOMATED SOLID PHASE TECHNOLOGY IN BLOOD GROUP TYPING
DETECTION OF WEAK D AMONG INITIALLY D-NEGATIVE EGYPTIAN BLOOD DONORS
P-230
ASSOCIATION OF RBC BLOOD GROUP ANTIBODY FORMATION AND HLA POLYMORPHISM
ANTIBODY SCREENING WITH PAPAIN-TREATED TEST ERYTHROCYTES DETECTS POTENTIALLY TRANSFUSION-RELEVANT ALLO-ANTIBODIES
FREQUENCY OF ABO AND RH (D) BLOOD GROUPS AMONG EGYPTIAN BLOOD DONORS
THE IMPLEMENTATION OF A NOVEL, FULLY AUTOMATED SYSTEM FOR THE IMMUNOHEMATOLOGIC TESTING OF BLOOD DONORS AT THE BLOOD TRANSFUSION CENTRE OF SLOVENIA
A PATIENT WITH A BLEEDING TENDENCY AND MULTIPLE ALLOANTIBODIES AGAINST RED CELL ANTIGENS: THE QUEST FOR COMPATIBLE BLOOD
RECONSIDERATION OF METHOD FOR DIRECT ANTIGLOBULIN TESTING IN CROATIAN BLOOD DONORS
DIFFICULTIES OF PERFORMING IMMUNOHAEMATOLOGICAL ANALYSES IN PATIENTS WITH AIHA
THE EFFECTS OF STORAGE TIME AND LEUKOCYTES BURDEN OF PACKED AND BUFFY-COAT DEPLETED RED BLOOD CELL UNITS ON RED CELL STORAGE LESION
FREQUENCY OF RED BLOOD CELL ALLOANTIBODIES IN CANCER PATIENTS: A TWO-YEAR RECORD
OPTIMAL IMMUNOHAEMATOLOGICAL METHOD-ETERNAL ENIGMA
CHARACTERIZATION OF ANTI-D MONOCLONAL ANTIBODY REA-GENTS BASED ON THEIR REACTIVITY WITH THE WEAK D PHENOTYPE
THE IMPORTANCE OF THE INFORMATION ABOUT THE FREQUENCY OF RHESUS BLOOD GROUP SYSTEM ANTIGENS AMONG SLOVENIAN BLOOD DONORS
DUFFY BLOOD GROUP GENOTYPING BY USING SURVEYOR NUCLEASE
REVIEW OF ALLOIMUNIZATION - CASE REPORT OF ANTICHIDO ANTIBODY
MOLECULAR POLYMORPHISM OF THE RH LOCUS IN D NEGATIVE ARGENTINEANS
RBC AUTO-IMMUNISATION AMONG TRANSFUSIONDEPENDANT MYELODYSPLASIC TUNISIAN PATIENTS
IMMUNE ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES (MDS)
SAFE BLOOD GROUPING FOR SAFE TRANFUSION
THE INCIDENCE OF RBC ALLOANTIBODIES IN HAEMOGLOBINOPATHIC PATIENTS
SEVERE AUTOIMMUNE HAEMOLYTIC ANAEMIA WITH NEGATIVE DAT IN THREE CHILDREN
POLYMORPHISM FUT2 GENE ANALYSIS IN SALIVA SAMPLES
PROPHYLATIC PHENOTYPE MATCHING OF DONOR RED BLOOD CELL UNITS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
STUDY OF BAND 3 PROTEIN IN SENESCENT ERYTHROCYTES
INCIDENCE OF RED CELL ALLOANTIBODIES UNDERLYING PANREACTIVE WARM AUTOANTIBODIES IN MULTITRANSFUSED EGYPTIAN PATIENTS
TOWARDS BETTER DETECTION OF IRREGULAR ANTIBODIES AT AMU HOSPITAL
BLOOD FILTRATION DECREASES INCIDENCE OF RED BLOOD CELLS ALLOIMMUNIZATION
ANALYSIS OF ALLO ANTIBODIES DETECTED IN CASES RECEIVED FOR PRE-TRANSFUSION COMPATIBILITY TESTING TO THE REFERENCE IMMUNOHAEMATOLOGY LABORATORTY NATIONAL BLOOD TRANSFUSION CENTER, SRI-LANKA
CHANGES OBSERVED AFTER SWITCH FROM TUBE TEST TO GEL MICROCOLUMN TECHNIQUE IN PRETRANSFUSION TESTING, WITH FACTORS POSSIBLY INFLUENCING THE BENEFITS
MODIFICATIONS OF THE RH COMPLEX EPITOPES DURING ERYTHROCYTE SENESCENCE
RED CELL ALLOIMMUNIZATION AMONG ANTENATAL PATIENTS IN HOSPITAL UNIVERSITI SAINS MALAYSIA
A NOVEL RH D VARIANT ‘DFW-2’
ALLOIMMUNIZATION AMONG TRANSFUSION DEPENDENT THALASSEMIA PATIENTS
RED BLOOD CELL ANTIBODIES AS A PREDICTOR OF HLA IMMUNIZATION IN PATIENTS SUBMITTED TO LIVER TRANSPLANT
COMPARISON OF THE PRESENCE OF CW ANTIGEN OF THE RHESUS BLOOD SYSTEM IN BLOOD DONORS AND PATIENTS USING SEROLOGY AND MOLECULAR TECHNIQUES
SEQUENCING ANALYSIS OF RHD INTRON 7 AND 9
SPECIFIC BLOCKING OF JK ANTIGENS IN AN APPARENTLY HEALTHY POTENTIAL BLOOD DONOR WHO PHENOTYPED AS JK (A-B-) REVEALS AN AUTOANTI-JK3
PARABOMBAY PHENOTYPE IN AN INDIAN PROBAND RESULTING FROM HOMOZYGOSITY FOR A NOVEL FUT1 ALLELE
ANTI-D AS A CONSEQUENCE OF RHD INCOMPATIBLE TRANSFUSIONS - RETROSPECTIVE ANALYSIS
12 CASES OF RHD DISCREPANCIES IN A GREEK TERTIARY HOSPITAL: CORRELATION BETWEEN SEROLOGY AND MOLECULAR TYPING
ACTIVITIES AND POTENTIALITIES OF CELLULAR AND GENETIC ENGINEERING LABORATORY
EXTERNAL QUALITY ASSESSMENT IN BLOOD TRANSFUSION LABORATORY- FIVE YEAR EXPERIENCE
P-272
P-273
FREQUENCY OF ERYTHROCYTE ANTIGEN PHENOTYPES AMONG BLOOD DONORS IN NORTHWESTERN GREECE
ANTI-A AND ANTI-B TITERS IN GROUP O BLOOD DONORS IN NORTH- WESTERN GREECE
EVALUATION OF A GEL-BASED SHOTGUN PROTEOMICS APPROACH AS A POWERFUL TOOL IN IDENTIFICATION OF OXIDATIVELY MODIFIED PROTEINS IN RBC MEMBRANES DURING BLOOD STORAGE
P-277
EVALUATION OF INFECTIOUS DISEASES IN PREGNANT WOMEN IN THRIASSIO REGION DURING A PERIOD OF 3 YEARS
MINERALOCORTICOID FUNCTION OF THE ADRENAL CORTEX IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
SINGLE CASE OF PERICARDIAL EFFUSION IN PATIENT WITH FAMILIAL MEDITERRANEAN FEVER
EVALUATION OF THE EFFICACY AND SAFETY OF THERAPEUTIC PHLEBOTOMY FOR DIFFERENT ETIOLOGIES OF HYPERFERRITINEMIA
RATIONAL TRANSFUSION THERAPY DURING CESAREAN SECTION
ERYTHROCYTES AUTOANTIBODIES IN PEDIATRIC PATIENTS WITH SICKLE CELLS DISEASE: A CASE REPORT OF ANTI-D AUTOANTIBODIES
PREFERENTIAL COLLECTION OF APHERESIS PHENOTYPED RED CELL CONCENTRATES USING ALYX COMPONENT COLLECTION SYSTEM
A COMPARISON OF THE PLATELET YIELD BETWEEN TWO APHERESIS SYSTEMS: THE HAEMONETICS MCS + AND GAMBRO BCT TRIMA ACCEL
CLINICAL APHERESIS - ISSUES AND EXPEREIENCE AT KING KHALID NATIONAL GUARD HOSPITAL, JEDDAH, KSA
P-287
GRANULOCYTE APHERESIS COLLECTION USING CORTICOSTEROIDS FOR DONORS STIMULATION
P-289
ADSORPTIVE GRANULOCYTE/MONOCYTE APHERESIS (ADACOLUMN) FOR THE TREATMENT OF RELAPSED RHEUMATOID ARTHRITIS: A CASE REPORT
GUILLAIN-BARRE SYNDROM IN ADULTS:RESPONSE TO PLASMA EXCHANGE
DONOR SAFETY AND TOLERANCE IN COLLECTION OF TRIPLE PLATELET DOSES. RESULTS FROM 2249 APHERESIS OF A MULTICENTER TRIAL
SAFETY AND EFFICACY OF THE GRANULOCYTE/MONOCYTE APHERESIS IN THE TREATMENT OF A PSORIATIC ARTHRITIS CASE
ERYTHROCYTAPHERESIS AS RESCUE THERAPY IN A PATIENT AFFECTED BY POLYCYTHEMIA VERA
ATYPICAL THERAPEUTIC RESPONSE TO PLASMA EXCHANGE IN A CASE OF MIXED CRIOGLOBULINEMIA HCV ASSOCIATED
HEMATOPOIETIC STEM CELLS AUTO-GRAFT IN MOROCCO
EVALUATION OF PLATELET COLLECTION USING THE NEW AMICUS SOFTWARE (3.0)
EFFECTS OF G-CSF SCHEDULE FOR HARVESTING PERIPHERAL BLOOD PROGENITOR CELLS FROM HEALTHY DONORS
MULTICOMPONENT APHERESIS - FURTHER PROGRESS IN BLOOD DONATION
THERAPEUTIC PHLEBOTOMY BY A PATIENT WITH HEREDITARY HAEMOCHROMATOSIS
A REVIEW AND AN EVALUATION OF 2597 CASES OF BLOOD TRANSFUSION IN SHENZHEN
ORAL ANTICOAGULANT THERAPY
CONTENT ANALYSIS OF BOOK OF IMPRESSIONS AS A METHOD OF EVALUATING CLINICAL TRANSFUSION THERAPEUTIC TREATMENT
EXPERENCE IN THE ESTABLISHMENT OF A MOLECULAR METHOD FOR HLA CLASS II TYPING
1137 UNITS OF BLOOD COMPONENTS RECEIVED BY A PATIENT IN JUST A BIT MORE THAN SIX MONTHS TIME
SUPPLY AND USE OF PLATELET CONCENTRATES IN GENERAL HOSPITAL UZICE (5 YEAR EXPERIENCE)
HLA COMPATIBILITY IN 220 PATIENTS WITH RENAL TRANSPLANTATION
RELATIONSHIP BETWEEN BLOOD GROUP OF ABO BLOOD GROUP SYSTEM AND CORONARY ARTERIAL DISEASE
TRANSFUSION SUPPORT IN LIVER TRANSPLANTATION - OUR EXPERIENCE
EVALUATION OF PLATELET CONCENTRATES STORED FOR 7 DAYS IN PVC-CITROFLEX B-6 CONTAINERS STERILIZATED WITH TWO DIFFERENT METHODS
QUALITY CONTROLS OF RED BLOOD CELL CONCENTRATES FOR TRANSFUSION THERAPY IN PATIENTS AFFECTED BY BETA-THALASSEMIA
HAEMOGLOBIN VALUES AS INDICATION PARAMETER FOR TRANSFUZION
FIVE YEAR EXPERIENCE OF USAGE THE FRESH FROZEN PLASMA IN SURGERY
STORAGE OF BUFFY-COAT-DERIVED PLATELETS IN ADDITIVE SOLUTIONS: SCANNING ELECTRON MICROSCOPY OF PLATELETS STORED AT 22 DEGREES C AND 4 DEGREES C.
STORAGE OF BUFFY-COAT-DERIVED PLATELETS IN ADDITIVE SOLUTIONS: IN VITRO EFFECTS ON PLATELETS STORED IN REFORMULATED PAS SUPPLIED BY A 20% PLASMA CARRYOVER
NATURAL KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES KIR2DL1, KIR2DL2, AND KIR2DL3 ARE INVOLVED IN PSORIATIC ARTHRITIS
COMPARATIVE STUDY OF EFFICACY OF LEUCOREDUCTION USING PREDEPOSIT LEUCOREDUCTION FILTERS AND BED SIDE LEUCOREDUCTION FILTERS AT DIFFERENT TEMPERATURES AND TO ASSESS NEED OF UNIVERSAL LEUCOREDUCTION
CONTROL OF PROTROMBIN TIME AND ORDINATING OF ANTICOAGULANT THERAPY- OUR EXPERIENCES
CONSEQUENCES OF LOW POSTOPERATIVE HAEMOGLOBIN LEVELS ON LENGTH OF HOSPITAL STAY AFTER ELECTIVE ORTHOPAEDIC SURGERY IN AN ELDERLY POPULATION
TOLERABILITY OF DEFERIPRONE IN A NEUTROPENIC PATIENT USING PEGYLATED INTERFERON AND RIBAVIRIN: A CASE REPORT
THE EFFECT OF ADDITIVE SOLUTION ON PLATELET FUNCTION IN PLATELET CONCENTRATES PREPARED USING DIFFERENT METHODS AND STORED OVER 7 DAYS
SURVEY OF THE FRESH FROZEN PLASMA CONSUMPTION AT THE CLINICAL CENTER OF SERBIA SURGICAL WARDS
CARDIOPATM AUTOTRANSFUSION SYSTEM IN PATIENTS UNDERGOING CARDIOVASCULAR SURGERY
P-324
FFP - ARE WE USING APPROPRIATELY?
RATIONAL USE OF BLOOD AND BLOOD PRODUCTS IN SURGICAL AND ALLIED DEPARTMENTS: COMPARATIVE ASSESSMENT OF A PUBLIC AND A PRIVATE HOSPITAL IN ISLAMABAD
REASONS OF NONUTILIZATION OF BLOOD UNITS
CLINICAL AUDIT OF THE USE OF PLATELET IN A TERTIARY TEACHING HOSPITAL
BLOOD UTILIZATION TRENDS AFTER IMPLEMENTATION OF THE NATIONAL GUIDELINES OF APPROPRIATE CLINICAL USE OF BLOOD IN NBTC
EFFECT OF IMPLEMETATION OF APPROPRIAT CLINICAL USE OF BLOOD (AUB) PROGRAM ON BLOOD COMPONENTS' UTILIZATION IN 6 OCTOBER HEALTH INSURANCE HOSPITAL
ARE MULTITRANSFUSED PATIENTS TRANSFUSED ACCORDING TO THE GUIDELINES?
THE CONTRIBUTION OF THE BLOOD BANK ELECTRONIC FILE FOR THE TRANSFUSION GOVERNANCE IN A UNIVERSITY HOSPITAL
ANEMIA AND PROGNOSIS OF CERVICAL CANCER FOLLOWING RADICAL HYSTERECTOMY
ORTHOPAEDIC TRANSFUSION PRACTICE IN A UK TEACHING HOSPITAL: AN AUDIT
AUTOLOGOUS DONATION PROGRAM IMPLEMENTATION: PREDEPOSIT AND AUTOTRANSFUSION OF SHED BLOOD IN ORTHOPEDIC SURGERY
ACHIEVING SOLUTIONS BY CONSENSUS TO ESTABLISH QUALITY TRANSFUSION PROTOCOLS AFTER ASSESSING THE CURRENT TRANSFUSION PRACTICES AT A TERTIARY CARE CENTRE IN A DEVELOPING COUNTRY
P-337
P-338
THE EFFECT OF PRESTORAGE FILTERATION ON PLATELET ACTIVATION IN PLATELET CONCENTERATES
THE USE OF BLOOD COMPONENTS AT UNIVERSITY CLINICAL CENTER MARIBOR AND GENERAL HOSPITAL CELJE IN THE PERIOD 1998-2007
UTLIZATION OF RED CELL CONCENTRATE AT THE NATIONAL HOSPITAL OF SRI LANKA FOR A PERIOD OF FOUR YEARS
FIRST REPORT OF TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI) IN SLOVENIA
DONOR SEX AND TRANSFUSION-RELATED ACUTE LUNG INJURY: A CASE-REFERENT STUDY FROM THE INTERNATIONAL TRALI UNISEX RESEARCH GROUP
STUDYING THE CONTRIBUTION OF DONOR ANTIBODIES TO THE OCCURENCE OF TRALI: A DISCUSSION OF METHODOLOGICAL SOLUTIONS TO OBTAINING AN UNBIASED ESTIMATE
TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI) IN A SURGICAL POLYTRANSFUSED PATIENT: A CASE REPORT
A NOVEL METHOD FOR SIMULTANEOUS ANALYSIS OF SPECIFIC GRANULOCYTE ANTIBODIES: SASGA
RESIDUAL WHOLE LEUKOCYTES IN FRESH FROZEN PLASMA (FFP) AND POSSIBLE RISK OF ALLOIMMUNIZATION
P-348
RELATION BETWEEN VITAMIN B12-FOLATE DEFICIENCY AND HYPERHOMOCYSTEINEMIA IN IRANIAN PATIENTS WITH THROMBOSIS
PROPHYLAXIS PROGRAM IN HEMOFILIA. FIVE YEARS OF EXPERIENCE
REPORTING OF ACTUAL AND NEAR-MISS EVENTS FOR TRANSFUSION MEDICINE: IMPROVING TRANSFUSION SAFETY, IRAN, 2006-2007
TRACEABILITY OF RED BLOOD CELLS COMPONENTS: A TWO STAGE AUDIT ON THE ACCURACY OF TRACEABILITY RECORDS IN KUWAIT CENTRAL BLOOD BANK AND TWO SMALL HOSPITALS BLOOD BANKS
ONE-YEAR EXPERIENCE OF PLATELET TRANSFUSION IN A TEACHING HOSPITAL
AN ACTIVE HEMOVIGILANCE PROGRAM UTILIZING AN EDC SYSTEM TO ASSESS SAFETY OF 6359 PLASMA COMPONENT TRANSFUSIONS PREPARED WITH THE INTERCEPT BLOOD SYSTEM
VIRAL HEPATITIS C AT HAEMATOLOGIC PATIENTS
FEBRILE NONHAEMOLITIC POSTTRANSFUSION REACTIONS-SEVEN YEARS OF EXPERINCE
VALIDATION MARKERS: NEWS AND OUTLOOK
HAZARDS OF TRANSFUSION THERAPY: LABORATORY INVESTIGATION AND CLINICAL OUTCOMES
DATA EXCHANGE IN TRANSFUSION MEDICINE: THE EDITAL DATABASE IMPROVES THE PATIENTS' CARE COORDINATION AND TRANSFUSION TRACEABILITY AND SAFETY
PLATE BASE AND IMMEDIATE TRANSFUSIONAL INCIDENTS
THE HAEMOVIGILANCE IN SAIDA HOSPITAL ALGERIA AS PROSPECTIVE STUDY
PROPOSAL TO ESTABLISH A REGIONAL HAEMOVIGILANCE SCHEME FOR TRANSFUSION FACILITIES IN THE ARABIC SPEAKING COUNTRIES
HAEMOVIGILANCE IN THE NORDIC COUNTRIES: REPORT OF NEAR MISS EVENTS IN 2007
ADVERSE REACTIONS ASSOCIATED WITH BLOOD TRANSFUSION. PRELIMINARY DATA FROM THE HELLENIC NATIONAL HAEMOVIGILANCE COORDINATING CENTRE (SKAE), 2007
NEW BARCODE LABEL FOR THE CONFIDENTIAL UNIT EXCLUSION PROCESS REDUCES WASTE OF BLOOD PRODUCTS
REPORTED ERRORS IN BLOOD TRANSFUSION NIS-REVIEW AND ANALYSIS
SUDDEN INCREASED INCIDENCE OF TRANSFUSION REACTIONS DUE TO FAULTY BLOOD ADMINISTRATION SETS
TEN YEARS (1998-2007) OF COMPLAINT MANAGEMENT AT CROATIAN INSTITUTE OF TRANSFUSION MEDICINE (CITM)
TISSUE VIGILANCE IN THE NETHERLANDS
ANALYSIS OF BLOOD TRANSFUSION ADVERSE REACTIONS IN A TERTIARY UNIVERSITY HOSPITAL IN GREECE
ORGANIZATION AND VALIDATION OF A NEW PROCESSING CENTRE
RED CELL PHENOTYPES IN BLOOD DONORS AT NATIONAL BLOOD CENTRE (NBC), KUALA LUMPUR
CELL AGING, CLEARANCE AND APOPTOSIS-LIKE MECHANISMS ACTIVATED IN STORED PACKED RED BLOOD CELLS (PRBCS)
EVALUATION OF HAEMOLYSIS OF RED CELLS OCCURING ACCORDING TO PROCESSING METHOD & STORAGE MEDIUM - A COMPARISON OF HAEMOLYSIS IN TRIPLE VERSUS QUADRUPLE STORAGE BAG SYSTEMS
ASSESSMENT OF THE STORAGE LESION IN APHERESIS AND WHOLE BLOOD DERIVED PLATELET CONCENTRATES
STANDARIZATION OF PLATELET COMPONENTS TREATED WITH INTERCEPT PATHOGEN INACTIVATION AT KUWAIT CENTRAL BLOOD BANK
CROSS VALIDATION OF MACOTRONIC V4 AND MACOTRONIC B2 REGARDING PLASMA FACTOR RECOVERY
PROTEIN QUALITY OF PREVIOUSLY FROZEN PLASMA TREATED WITH THE MIRASOL PATHOGEN INACTIVATION PROCESS AND STORED FOR 2 YEARS
A NEW TOOL FOR INCREASING THE EFFICIENCY OF INTERCEPTTM PATHOGEN INACTIVATION (PI) SYSTEM FOR PLASMA
EVALUATION OF IN VITRO PLATELET PROPERTIES OF APHERESIS PLATELETS COLLECTED IN 100% PLASMA TREATED WITH INTERCEPT BLOOD SYSTEM AND STORED FOR UP TO NINE DAYS
EVALUATION OF IN VITRO QUALITY OF STORED RBC AFTER TREATMENT WITH THE S-303 TREATMENT PROCESS
PLATELETS RELEASING OF SOLUBLE GLYCOPROTEIN V (SGPV) DURING STORAGE INCREASES IN PSORALEN INACTIVATED PLATELETS
STORAGE STABILITY OF METHYLENE BLUE-TREATED PLASMA
HYBRID PARTICLE-NONWOVEN MEMBRANE SEPARATION MEDIUM FOR REMOVAL OF PATHOGENIC CONTAMINANTS FROM RED BLOOD CELL CONCENTRATE
STUDIES ON THE CAPACITY AND SPECIFICITY OF THE PCAPT PRION REMOVAL FILTER
BACTERIAL AND VIRAL INACTIVATION BY THE S-303 TREATMENT PROCESS FOR RED BLOOD CELLS (RBCS)
BIOCHEMICAL QUALITY OF THE PHARMACEUTICALLY LICENSED PLASMA OCTAPLAS AFTER IMPLEMENTATION OF A NOVEL PRION PROTEIN (PRPSC) REMOVAL TECHNOLOGY
IMPACT OF THE SOLVENT/DETERGENT (S/D) TREATMENT TIME ON PROTEASE INHIBITOR ACTIVITY IN THE PHARMACEUTICALLY LICENSED PLASMA OCTAPLAS LG
QALITY CONTROL OF RIBOFLAVIN-TREATED PLATELET CONCENTRATES (MIRASOL PRT SYSTEM)
TREATMENT OF DOUBLE DOSE PLATELET COMPONENTS WITH THE INTERCEPT BLOOD SYSTEM AND SUBSEQUENT STORAGE IN TWO CONTAINERS
THE EFFECT ON THE APHERESIS PLATELET FUNCTION OF PHOTOCHEMICAL TREATMENT PCT WITH UVA LIGHT AND RIBOFLAVIN
IMMUNE RESPONSE TO CHALLENGE OF LEUKOCYTE INJECTION AFTER TRANSFUSIONS OF MIRASOL TREATED PLATELETS IN RATS
MIRASOL TREATMENT OF PLATELETS SUSPENDED IN ADDITIVE SOLUTION
IN VITRO CELL QUALITY OF PLATELETS TREATED WITH MIRASOL ∩ PRT AT THE BEGINNING OF STORAGE AND GAMMA-IRRADIATED AT DIFFERENT TIMES DURING STORAGE
THE MIRASOL EVALUATION PROGRAM: USE OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY FOR PLATELETS IN ROUTINE CLINICAL PRACTICE
SUCCESSFUL TREATMENT OF A POST-PARTUM BLEEDING WITH THE VIRUS INACTIVATED FRESH FROZEN PLASMA SAFE: A CASE REPORT
THE INTRODUCTION OF A NOVEL PRION PROTEIN (PRPSC) REMOVAL TECHNOLOGY FOR THE PHARMACEUTICALLY LICENSED PLASMA (OCTAPLAS∩)
INFLUENCE OF MIRASOL? PATHOGEN REDUCTION TECHNOLOGY ON STORAGE PARAMETERS OF PLATELETS AND THEIR MITOCHONDRIAL POTENTIAL AND INTRACELLULAR CALCIUM CONTENT AS A STRESS MARKER
RELEASE OF ANNEXIN V DURING STORAGE OF APHERESIS-DERIVED PLATELETS AFTER DIFFERENT PATHOGEN REDUCTION TECHNOLOGIES
INTERCEPT PLASMA RETAINS COAGULATION FACTOR ACTIVITY WHEN PREPARED FROM DIFFERENT PLASMA SOURCES
PATHOGEN INACTIVATED PLASMA: A COMPARISON OF FOUR TECHNOLOGIES
INACTIVATION OF TRANSFUSION-TRANSMITTED VECTORBORNE PATHOGENS
THERAFLEX UV PLATELETS: REPRODUCIBLE STERILIZATION OF BACTERIA SPIKED PLATELET CONCENTRATES
USING REAL-TIME PCR TO EVALUATE THE EFFECT OF VIRAL INACTIVATION BY METHYLENE BLUE WITH VISIBLE LIGHT
P-405
CLONING AND EXPRESSION OF B-DOMAIN DELETED HUMAN FACTOR VIII CDNA IN MAMMALIAN CELLS
QUALITY INDICATOR TO EVALUATE IMPLEMENTATION OF THE BUFFY-COAT METHOD FOR THE PREPARATION OF POOLED PLATELET CONCENTRATES
EVALUATION OF PLATELET PRODUCTION AND CAUSES OF DISCARD RATES IN THE COIMBRA REGIONAL BLOOD CENTRE
EFFICACY OF WHITE BLOOD CELL FILTRATION OF RED BLOOD CELL CONCENTRATES; A COMPARISON BETWEEN THREE LEUKOREDUCTION INLINE FILTER SYSTEMS
APPLICATION EFFECT OF FIBRIN SEALANT IN PATIENTS UNDERGOING PACEMAKER IMPLANTATION
MARKERS OF OXIDATIVE AND INFLAMMATORY STRESS IN RED BLOOD CELL COMPONENTS DURING STORAGE
LEUKOREDUCTION POTENTIAL OF VARIOUS FILTERS ACCORDING TO TYPE OF RED BLOOD CELL CONCENTRATE
EVALUATION OF FROZEN-THAWED-DEGLYCEROLIZED RBCS AS QUALITY CONTROL MATERIALS FOR RBC DEFORMABILITY TEST
RED CELL CONCENTRATES IN YAOUNDÉ: WHICH QUALITY?
THE RESULTS OF THE QUALITY OF BUFFY-COAT DERIVED PLATELET CONCENTRATES
THE USE OF ALBUMIN AND IMMUNOGLOBULIN AT UNIVERSITY CLINICAL CENTER MARIBOR AND GENERAL HOSPITAL CELJE
P-416
RECOMBINANT FACTOR VIII CONCENTRATES: A COMPARATIVE STRUCTURAL ANALYSIS
TRANSFUSION ALTERNATIVES IN LIVER TRANSPLANTATION: SINGLE CENTER STUDY
CONDITION TRANSFUSION THE HELP TO PATIENTS WITH HEMOPHILIA IN ARMENIA
THE STUDY OF MEMBRANOUS PLASMAPHERESIS ACTION ON RHEOLOGICAL PROPERTIES OF BLOOD IN PATIENT WITH HEMORRHAGIC VASCULITIS
THE USE OF AUTOLOGOUS TRANSFUSION IN THE MILITARY MEDICAL ACADEMY
THE EFFECT OF GLUCOSE SUPPLY ON THE IN VITRO VIABILITY OF PLATELETS STORED AT 4?
THE EFFECT OF GROWTH FACTORS OF PLATELET GEL ON PROLIFERATION AND DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS TO OSTEOBLASTS AND OSTEOGENESIS
OPTIMIZING AUTOMATION - WHAT ELSE ALYX CAN DO
EXPLORING THE POSSIBLE USE OF RFID TECHNOLOGY IN TRANSFUSION MEDICINE
PROPERTIES OF AMD3100 MOBILIZED HEMATOPOIETIC STEM/PROGENITOR CELLS
SINGLE SITE RESULTS OF A MULTI CENTER STUDY: PERFORMANCE VALIDATION OF THE BD THROMBO COUNT ASSAY FOR FLOW CYTOMETRIC ENUMERATION OF RESIDUAL LEUCOCYTES AND RED BLOOD CELLS IN PLATELET CONCENTRATES
INITIAL RESULTS FROM THE QUALITY CONTROL LAB: USE OF THE BD THROMBO COUNT ASSAY IN ROUTINE FLOW CYTOMETRY ENUMERATION OF RESIDUAL LEUCOCYTES AND RED BLOOD CELLS IN PLATELET CONCENTRATES
IN VITRO FUNCTION OF PLATELET CONCENTRATES STORED IN SSP PLATELET ADDITIVE SOLUTION
L CARNITINE PROTECTS RED CELLS AGAINST OXIDATIVE INJURY DURING STORAGE
PERFORMANCE CHARACTERISTICS OF COMPOFLOW, A NOVEL BLOOD BAG IN-LINE CLOSURE DEVICE, AND SUBSEQUENT PRODUCT QUALITY ASSESSMENT
THE USE OF THE PLATELET RICH PLASMA TO ENHANCE THE BONY TISSUE REGENERATION IN THE TREATMENT OF THE SPLANCHNOCRANIUM CYSTS
PLATELET GEL AND WOUND CARE: THE WEIGHT OF THE PLATELETS CONCENTRATION IN THE CLINICIAN-THERAPEUTIC PRACTICE
PLATELET GEL COMBINED WITH TEICOPLANIN IN THE TREATMENT OF THE INFERIOR LIMBS ULCERS
BUFFY COAT FROM FRESH OR OVERNIGHT STORED BLOOD
DETECTION OF WEAK EXPRESSION OF D ANTIGEN AMONG D NEGATIVE C POSITIVE DONORS USING RBC GENOTYPING
BLOODCHIP V 2.0, A SINGLE TEST FOR HUMAN RED BLOOD CELL AND PLATELET ANTIGENS GENOTYPING
BLOOD PROGENITOR CELLS CHARACTERIZED BY IMMUNOFLUORESCENCE AND ALDEHYDE DEHYDROGENASE EXPRESSION
IN VITRO ANTIGEN SPECIFIC IMMUNE RESPONSES AFTER PLURIPOTENT AUTOLOGOUS DENDRITIC CELL VACCINATION OF NON-SMALL-CELL LUNG CANCER PATIENTS
THE VALUE OF ROUTINE PROCESS CONTROLS IN IMPROVING SAFETY IN INNUMOHAEMATOLOGY TESTING - 3 YEARS EXPERIENCE IN AUSTRALASIA
IS THE QUALITY OF BLOOD BANKED BLOOD QUESTIONABLE
P-442
P-443
COLLABORATIVE MULTICENTRIC STUDY FOR INTERNATIONAL STANDARDISATION OF RESIDUAL WHITE BLOOD CELL COUNTING OF RED BLOOD CELL CONCENTRATES
UMBILICAL CORD BLOOD (UCB) THAWING. DIFFERENCES IN THE CONTENT OF UCB UNITS AFTER THAWING DEPENDING ON THEIR ORIGIN. EXPERIENCE OF A SINGLE CENTRE
THE NETHERLANDS MILITARY BLOOD SUPPLY SYSTEM: FEATURES AND EXPERIENCES
INTRAOPERATIVE USE OF AUTOLOGOUS PLATELET GEL FOR THE REPLACEMENT OF AN ILIUM ARTHROPROSTHESIS
P-448
MASS-SCALE COMPREHENSIVE RHD GENOTYPING OF 3000 SAMPLES USING BLOODCHIP∩ V 1.0
MASS-SCALE EXTENSIVE GENOTYPING OF 3000 RBC SAMPLES BY BLOODCHIP∩ V 1.0
TRAINING IN CLINICAL RESEARCH RELEVANT TO INTERNATIONAL TRANSFUSION SAFETY
EXTENSIVE BLOOD GROUP GENOTYPING OF BLOOD DONORS FROM IMMIGRANT POPULATIONS: THE CHALLENGE OF A NEW REALITY IN THE SPANISH BLOOD DONOR AND PATIENT POPULATION
A NEW MODEL FOR HAEMOCOMPONENTS COLLECTION, BASED ON A MOBILE COLLECTION UNIT
PREPARATION OF BUFFY COATS WITH REDUCED AMOUNT OF RED CELLS: EFFECT ON HAEMOGLOBIN CONTENT AND PLATELET YIELD IN FINAL BLOOD COMPONENTS
OPTICAL METHODS TO EVALUATE ALTERATIONS IN ERYTHROCYTE AGGREGATION
TAP1 AND TAP2 POLYMORPHISMS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN A CHINESE POPULATION
P-457